ESCITALOPRAM 10mg. IP

An antidepressant drug that treats major depressive disorder and generalized anxiety disorder. (Landy, Rosani, & Estevez, 2022) Shows a preventive effect on major depressive disorder relapse and recurrence. (Kirino, 2012) An efficacious medicine in the treatment of patients with depression and anxiety symptoms. (Kaida Jiang, 2017) Demonstrates superiority in terms of both effectiveness and tolerability compared with duloxetine. (Raymond W Lam, 2008) An effective and well-tolerated first-line treatment option for the management of panic disorder, generalized anxiety disorder, social anxiety, and obsessive-compulsive disorder. (Pelissolo, 2008) Has better efficacy in the treatment of severe depression than citalopram. (J-M Azorin, 2004) A good therapeutic option as compared to paroxetine for the long-term treatment of the major depressive disorder. (Siegfried Kasper, 2009) More effective than citalopram 10 and 20 mg in outpatients with major depressive disorder. (Valery Y Yevtushenko, 2007) An effective and generally well-tolerated treatment for moderate to severe major depressive disorder. (Karly P Garnock-Jones, 2010) An efficacious, safe, and well-tolerated by the patient with social anxiety disorder. (Satoshi Asakura, 2016)